Mark J Alles's Net Worth
$28.5 Million
Who is Mark J Alles?
Mark J Alles has an estimated net worth of $28.5 Million. This is based on reported shares across multiple companies, which include Turning Point Therapeutics, Inc., BIOMARIN PHARMACEUTICAL INC, Syros Pharmaceuticals, Inc., and CELGENE CORP /DE/.
SEC CIK
Mark J Alles's CIK is 0001538897
Past Insider Trading and Trends
2015 was Mark J Alles's most active year for acquiring shares with 44 total transactions. Mark J Alles's most active month to acquire stocks was the month of January. 2015 was Mark J Alles's most active year for disposing of shares, totalling 42 transactions. Mark J Alles's most active month to dispose stocks was the month of January. 2013 saw Mark J Alles paying a total of $6,330,262.96 for 199,471 shares, this is the most they've acquired in one year. In 2013 Mark J Alles cashed out on 244,966 shares for a total of $16,397,873.10, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Turning Point Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -2.00K |
$76.00 | -$152,000.00 |
0
|
Aug 17
| |||
Form 4
|
∞
| 2K |
$81.34 | $162,680.00 | 2K |
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BIOMARIN PHARMACEUTICAL INC (BMRN) Snapshot price: $83.7
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +38.42% | 4.19K |
—
|
—
| 15.1K |
May 23
| |||
Form 4
| +49.79% | 3.63K |
$86.75 | $314,468.75 | 10.9K |
Oct 31
| |||
Form 4
| +216.52% | 4.98K |
—
|
—
| 7.28K |
May 24
| |||
Form 4
|
∞
| 2.3K |
—
|
—
| 2.3K |
Jan 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Syros Pharmaceuticals, Inc. (SYRS) Snapshot price: $1.6
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +266.60% | 2.67K |
—
|
—
| 3.67K |
Sep 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
∞
| 10K |
$8.86 | $88,590.00 | 10K |
May 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CELGENE CORP /DE/ No price found
CEO, CHAIRMAN OF BOARD
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -227.52K |
—
|
—
|
0
|
Nov 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 20
| |||
Form 4
| +4.23% | 8.99K |
$95.21 | -$630,290.20 | 221.27K |
May 2
| |||
Form 4
| +10.35% | 19.91K |
$85.96 | -$1,194,844.00 | 212.28K |
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 28
| |||
Form 4
| +2.70% | 5.05K |
$68.20 | -$264,343.20 | 192.37K |
Dec 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 30
| |||
Form 4
| +0.65% | 1.21K |
$82.60 | $99,784.42 | 187.32K |
May 8 - May 9
| |||
Form 4
| +1.08% | 1.98K |
$86.89 | -$131,985.91 | 186.11K |
May 4
| |||
Form 4
| +2.92% | 5.22K |
$95.26 | -$196,235.60 | 184.13K |
Feb 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
| +1.86% | 3.26K |
$91.90 | $299,594.00 | 178.9K |
Feb 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
| +1.42% | 2.46K |
$107.06 | -$224,183.64 | 175.64K |
Dec 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 30
| |||
Form 4
| +1.33% | 2.27K |
$134.10 | -$259,081.20 | 173.19K |
Jul 28 - Jul 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
| +4.78% | 7.8K |
$117.02 | -$777,363.86 | 170.92K |
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30
| |||
Form 4
| +2.22% | 3.54K |
$117.63 | -$355,007.34 | 163.12K |
Dec 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 1
| |||
Form 4
| +3.86% | 5.94K |
$103.41 | -$523,461.42 | 159.57K |
Apr 29 - May 2
| |||
Form 4
| +9.99% | 13.95K |
$102.45 | -$1,218,028.05 | 153.64K |
Feb 12
| |||
Form 4
| +18.63% | 21.94K |
$27.51 | $603,585.89 | 139.69K |
Jan 29 - Feb 1
| |||
Form 4
| +5.65% | 6.3K |
$112.17 | -$602,352.90 | 117.75K |
Dec 16 - Dec 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 27
| |||
Form 4
| +5.74% | 6.05K |
$108.06 | -$556,941.24 | 111.45K |
Apr 30 - May 4
| |||
Form 4
| +4.21% | 4.26K |
$121.53 | -$495,599.34 | 105.4K |
Mar 1
| |||
Form 4
| +37.35% | 27.5K |
$45.43 | $1,249,652.93 | 101.14K |
Feb 12
| |||
Form 4
| +11.34% | 7.5K |
$81.12 | -$11,250,879.82 | 73.64K |
Scheduled
|
Feb 6
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 28
| |||
Form 4
| +33.78% | 8.35K |
$160.54 | -$1,097,611.98 | 33.07K |
Feb 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 4
| +20.92% | 4.28K |
$168.93 | -$591,423.93 | 24.72K |
Dec 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 2
| |||
Form 4
| +36.79% | 5.5K |
$151.31 | -$681,175.11 | 20.44K |
Nov 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 28
| |||
Form 4
| +202.18% | 10K |
$101.90 | -$8,574,718.10 | 14.95K |
Jul 31 - Aug 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 29
| |||
Form 4
| +129.62% | 2.79K |
$123.00 | -$220,293.00 | 4.95K |
Apr 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 30
| |||
Form 4
|
∞
| 2.15K |
$78.32 | -$70,644.64 | 2.15K |
Apr 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||